The latest closing stock price for Stoke Therapeutics as of January 21, 2025 is 9.80.
An investor who bought $1,000 worth of Stoke Therapeutics stock at the IPO in 2019 would have $-617 today, roughly -1 times their original investment - a -14.77% compound annual growth rate over 6 years.
The all-time high Stoke Therapeutics stock closing price was 69.81 on January 19, 2021.
The Stoke Therapeutics 52-week high stock price is 17.58, which is 79.4% above the current share price.
The Stoke Therapeutics 52-week low stock price is 4.09, which is 58.3% below the current share price.
The average Stoke Therapeutics stock price for the last 52 weeks is 11.86.
An investor who bought $1,000 worth of Stoke Therapeutics stock at the IPO in 2019 would have $-617 today, roughly -1 times their original investment - a -14.77% compound annual growth rate over 6 years.
The all-time high Stoke Therapeutics stock closing price was 69.81 on January 19, 2021.
The Stoke Therapeutics 52-week high stock price is 17.58, which is 79.4% above the current share price.
The Stoke Therapeutics 52-week low stock price is 4.09, which is 58.3% below the current share price.
The average Stoke Therapeutics stock price for the last 52 weeks is 11.86.